Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer
Clinical trial NCT00209677 · SUSPENDED
Trial details
- NCT number
- NCT00209677
- Sponsor
- Hokkaido Gastrointestinal Cancer Study Group
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.